Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.480
0.00 (0.00%)
At close: Aug 28, 2025, 4:00 PM
1.340
-0.140 (-9.46%)
After-hours: Aug 28, 2025, 7:59 PM EDT

Telomir Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.751.2700-
Cash & Short-Term Investments
0.751.2700-
Cash Growth
-59.96%102753.86%-13.25%--
Prepaid Expenses
0.080.060--
Other Current Assets
--0.430.05-
Total Current Assets
0.831.320.440.05-
Long-Term Deferred Charges
--4.34--
Total Assets
0.831.324.770.05-
Accounts Payable
0.250.590.710.40.02
Short-Term Debt
0.090.090.630.580.12
Total Current Liabilities
0.350.681.340.990.14
Total Liabilities
0.350.681.340.990.14
Additional Paid-In Capital
38.3331.2417.50.060.06
Retained Earnings
-37.85-30.6-14.06-0.99-0.14
Comprehensive Income & Other
-----0.06
Shareholders' Equity
0.480.643.44-0.94-0.14
Total Liabilities & Equity
0.831.324.770.05-
Total Debt
0.090.090.630.580.12
Net Cash (Debt)
0.661.17-0.63-0.58-0.12
Net Cash Per Share
0.020.04-0.02-0.02-
Filing Date Shares Outstanding
32.2829.7629.6127.1-
Total Common Shares Outstanding
30.5129.7628.6126.83-
Working Capital
0.480.64-0.9-0.94-0.14
Book Value Per Share
0.020.020.12-0.03-
Tangible Book Value
0.480.643.44-0.94-0.14
Tangible Book Value Per Share
0.020.020.12-0.03-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q